HomeAI · summaries
Storia in 18 fonti
AstraZeneca may buck a decade of pharma strategy to buy U.S. scale
Reports of preliminary talks between AstraZeneca and Bristol Myers Squibb moved shares and reignited debate over Big Pharma consolidation.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
wiwo.de
Pharmaindustrie: Investoren gegen Fusion von AstraZeneca und BMS
Der britische Pharmakonzern und sein US-Konkurrent Bristol Myers Squibb wollen wohl fusionieren. Doch Anleger lehnen das offenbar ab. Nach Bekanntwerden der Gerüchte brach der…
- ·
zerohedge.com
$400 Billion Pharma Megadeal? Jefferies Calls Potential AstraZeneca-Bristol Myers Merger A "Head Scratcher"
"Why" is perhaps not yet clear to us: We suspect that most people will focus on the potential to establish an even bigger oncology powerhouse...
